Donate Today for GivingTuesday 2023
As a non-profit 501(c)3 organization, FWGBD depends on the support of our members, donors, partners, and grants to further our mission to ensure all women…
Read Our News
Did you miss our most recent webinar? The recording is now available!
Watch our most recent program, Caring for Women Dental Patients on Antithrombotic Medication, featuring Dr. James Curtis and Dr. Rachel Rosovsky!
Apply today for the ASH Clinical Research Training Institute
The ASH Clinical Research Training Institute (CRTI) in North America is a unique, year-long education and mentoring program for hematology fellows and junior faculty at academic medical…
A Letter from FWGBD Board President, Dr. Sarah H. O’Brien
Dear FWGBD Community, As those of you who attended our conference last weekend will have heard, I have officially begun my term as the new…
New Publication from the WGBD LAN: Trends in dedicated care for females with bleeding disorders within U.S. hemophilia treatment centers
The Foundation for Women & Girls+ with Blood Disorders is pleased to share the publication of a collaborative WGBD LAN article, Trends in dedicated care…
A Letter from Founding Board President, Dr. Andra James
Dear FWGBD Community, It is with profound gratitude that I write to you today to announce that I am stepping down from my position as…
Hemostatic considerations for gender affirming care – New Publication from the WGBD LAN – Thrombosis Subcommittee
FWG+BD is proud to share the recent publication of, Hemostatic considerations for gender affirming care, found in Thrombosis Research. WGBD LAN members who authored this…
Upcoming CDC Webinar! Venous Thromboembolism: Understanding Psychosocial Factors and Mental Health of the Patient
Please join the CDC for their next Public Health Webinar Series on Blood Disorders, scheduled for September 28, 2023, at 2:00 PM ET. In this…
NEW! Sickle Cell Disease and Pregnancy Fact Sheets
Women with sickle cell disease (SCD) are at greater risk for developing health problems during pregnancy than women without SCD. In collaboration with the National Center on…
Recording Available! Case Conversation: Alternative routes for tranexamic acid treatment in obstetric bleeding (WOMAN-PharmacoTXA trial)
Recorded on July 26th, 2023, this FWGBD Case Conversation features Drs. Homa K. Ahmadzia, Monica Arribas, and Jamil Kazma, as they introduce the recent publication,…
Join us at the 2023 NHLBI Annual Sickle Cell Disease Research Meeting
Please join FWGBD at the 2023 NHLBI Annual Sickle Cell Disease Research Meeting. The 3-day meeting will commence on August 14, 2023, at 9:00 am…
DDAVP Nasal Spray Shortage – Meeting Patients’ Needs
With the prospect of a product shortage for Desmopressin Acetate Nasal Spray extending well into 2023, The Hemophilia Alliance began searching for another source of a Desmopressin…
FDA Approval of US First OTC Contraceptive
Access to reproductive healthcare options has recently expanded in the United States due to the FDA’s recent approval of the country’s first over-the-counter (OTC) contraceptive.…
FWGBD Members Recognized Among 2023 ASH Honorific Awards
FWGBD would like to congratulate two of our leaders and supporters as 2023 Honorific Award Recipients from the American Hematology Society (ASH): Alexis A. Thompson,…
ASH Clinical News Feature with FWGBD Co-Founder, Dr. Barbara Konkle
It is with much pleasure that we share, Pulling Back the Curtain: Barbara A. Konkle, MD, an ASH Clinical News interview published in April 2023. This…
